CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, today announced that it will provide an update on the Company’s clinical and preclinical progress at the 2008 Boston Biotech R&D Conference on Wednesday, October 22, 2008 at Harvard Medical School.
